Article

A Potential Novel COVID-19 Vaccine With RBD-HR1/HR2 Hexamer Structure

2021-10-29

Abstract excerpt

<h4>ABSTRACT</h4> The COVID-19 pandemic and the continued spreading of the SARS-CoV-2 variants have brought a grave public health consequence and severely devastated the global economy with recessions. Vaccination is considered as one of the most promising and efficient methods to end the COVID-19 pandemic and mitigate the disease conditions if infected. Although a few vaccines have been developed with an unprece...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8ef1a71c-8085-58fa-a548-df183bd9e217
DOI: 10.1101/2021.10.28.465226

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Potential Novel COVID-19 Vaccine With RBD-HR1/HR2 Hexamer StructureDOI 10.1101/2021.10.28.465226Read

Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopesSemantic proximity Read

Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBDSemantic proximity Read

Designing a T cell multi-epitope vaccine against hRSV with reverse vaccinology: an immunoinformatics approachSemantic proximity Read

Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants.Semantic proximity Read

Immunoinformatics design of Bivalent Vaccine targeting S1-NTD and HA2 to simultaneously protect against SARS-CoV-2 and Influenza infectionsSemantic proximity Read

Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2Semantic proximity Read

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variantSemantic proximity Read

Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.Semantic proximity Read

A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of ConcernSemantic proximity Read

Translational Virology - COVID-19, The Perfect ExampleSemantic proximity Read

SARS-CoV-2 vaccines - the biggest medical research project of the 21st century.Semantic proximity Read

Recombinant protein HR212 targeting heptad repeat 2 domain in spike protein S2 subunit elicits broad‐spectrum neutralizing antibodies against SARS‐CoV‐2 and its variantsSemantic proximity Read